Plexus reported fiscal first quarter 2021 revenue of $830 million and GAAP diluted EPS of $1.23. The company initiated fiscal second quarter 2021 revenue guidance of $860 to $900 million with GAAP diluted EPS of $1.17 to $1.32.
Won 35 manufacturing programs during the quarter representing $223 million in annualized revenue when fully ramped into production
Trailing four quarter wins total a record $1 billion in annualized revenue when fully ramped into production
Expanded GAAP operating margin to 5.6% through focus on productivity improvements and expense management
Delivered return on invested capital of 16.3%, sequentially improved by 230 basis points
Plexus anticipates a robust fiscal second quarter due to expected increases in medical equipment demand, recent strengthening in our Industrial Sector and sustained operational excellence. The company is guiding revenue of $860 to $900 million and GAAP diluted earnings per share of $1.17 to $1.32.